Search…

Lates News

23/09/2025

According to CME's "FedWatch": The probability of the Fed cutting interest rates by 25 basis points in October is 89.8%, while the probability of keeping rates unchanged is 10.2%.

Latest

2 m ago

Nvidia has stated that despite reaching an agreement with OpenAI, all customers will remain a "top priority."

3 m ago

The Australia Standard & Poor's/Australian Stock Exchange 200 index rose 0.3% in early trading to 8835.20 points.

5 m ago

In the morning of September 23, Kolonbo Shengwu announced on the Hong Kong Stock Exchange that the new drug application (NDA) for the rearranged during transfection (RET) small molecule kinase inhibitor project A400 (also known as EP0031) has been accepted by the China National Medical Products Administration (NMPA) Drug Evaluation Center (CDE) for the treatment of RET fusion-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) in adult patients.

5 m ago

Kolonbo Tai Biological: A400/EP0031 New Drug Market Application Accepted by National Drug Administration.

5 m ago

"Our country ushers in the eighth Chinese Farmers' Harvest Festival."

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services